This trial will test if a combination of two drugs is effective and safe for treating Gulf War Illness, a condition with many symptoms that can be debilitating.
2 Primary · 1 Secondary · Reporting Duration: Baseline and 24 weeks
Experimental Treatment
20 Total Participants · 2 Treatment Groups
Primary Treatment: Etanercept · No Placebo Group · Phase 1
Age 45 - 70 · Male Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: